Asabys Partners, a venture capital manager specializing in biomedicine, a member of CataloniaBio & HealthTech, raises its first fund to 117 million euros. The expansion of the Sabadell Asabys vehicle, with a closure of 87 million, is due to an investment of 30 million from the European Investment Fund (EIF).
The entry of the new investor is structured through the creation of a new vehicle, Asabys Top Up Fund, which will act in a complementary way to Sabadell Asabys. The mission of the associated fund is to strengthen the investment capacity of the current portfolio of companies in the face of new rounds of investment.
Speaking to the press, the managing partner, Josep Lluís Sanfeliu, explained that "the FEI's investment is a double recognition as it is committed to both the management of Asabys and the portfolio companies". It also reduces the risk for many of the investments, explains Sanfeliu, "we can support our investees in case they have more financial needs, such as complementary studies required by regulators."
Comments